{"DataElement":{"publicId":"3234684","version":"1","preferredName":"Laboratory Procedure Genetic Abnormality Test Method Type","preferredDefinition":"Text term to classify the testing method used to determine the genetic abnormality.","longName":"3234659v1.0:3234682v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3234659","version":"1","preferredName":"Laboratory Procedure Genetic Abnormality Test Performed","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Abnormalities that occur in human cells and tissues and models of human cancer._A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._Performed; carried out.","longName":"2543047v1.0:3234657v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3234657","version":"1","preferredName":"Molecular Abnormality Test Performed","preferredDefinition":"Abnormalities that occur in human cells and tissues and models of human cancer.:A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.:Performed; carried out.","longName":"C3910:C47891:C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular Abnormality","conceptCode":"C3910","definition":"A molecular or cytogenetic abnormality which occurs in either human disease states or disease models.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Test","conceptCode":"C47891","definition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3156BEA-4C57-681A-E040-BB89AD43563C","latestVersionIndicator":"Yes","beginDate":"2011-05-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-12","modifiedBy":"ONEDATA","dateModified":"2011-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3156BEA-4C68-681A-E040-BB89AD43563C","latestVersionIndicator":"Yes","beginDate":"2011-05-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Released per approval by B. McClure-Shimel. mc 5/12/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3234682","version":"1","preferredName":"Genetic Abnormality Test Method Type","preferredDefinition":"Abnormalities that occur in human cells and tissues and models of human cancer._A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._Type; a subdivision of a particular kind of thing.","longName":"3234682v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Cytogenetics","valueDescription":"Cytogenetic Analysis","ValueMeaning":{"publicId":"2861225","version":"1","preferredName":"Cytogenetic Analysis","longName":"2861225","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"679D66C6-4660-310F-E040-BB89AD4302D9","latestVersionIndicator":"Yes","beginDate":"2009-04-15","endDate":null,"createdBy":"CZECHS","dateCreated":"2009-04-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3158B0D-1549-9FBA-E040-BB89AD431012","beginDate":"2011-05-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-12","modifiedBy":"ONEDATA","dateModified":"2011-05-12","deletedIndicator":"No"},{"value":"FISH","valueDescription":"Fluorescence in situ Hybridization","ValueMeaning":{"publicId":"2581337","version":"1","preferredName":"Fluorescence in situ Hybridization","longName":"2581337","preferredDefinition":"A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0AC6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-24","modifiedBy":"ONEDATA","dateModified":"2006-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3158B0D-1554-9FBA-E040-BB89AD431012","beginDate":"2011-05-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-12","modifiedBy":"ONEDATA","dateModified":"2011-05-12","deletedIndicator":"No"},{"value":"Southern Blot","valueDescription":"Southern Blotting","ValueMeaning":{"publicId":"3121572","version":"1","preferredName":"Southern Blotting","longName":"3121572","preferredDefinition":"A technique for the detection of specific DNA fragments that have been separated by polyacrylamide-gel electrophoresis, transferred to a nitrocellulose or other type of paper or nylon membrane, and detected by hybridization and visualization with a labeled probe.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Southern Blotting","conceptCode":"C16356","definition":"A technique for the detection of specific DNA fragments that have been separated by polyacrylamide-gel electrophoresis, transferred to a nitrocellulose or other type of paper or nylon membrane, and detected by hybridization and visualization with a labeled probe.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5C8518-E9D9-522C-E040-BB89AD43153D","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3158B0D-1568-9FBA-E040-BB89AD431012","beginDate":"2011-05-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-12","modifiedBy":"ONEDATA","dateModified":"2011-05-12","deletedIndicator":"No"},{"value":"PCR","valueDescription":"Polymerase Chain Reaction","ValueMeaning":{"publicId":"3234683","version":"1","preferredName":"Polymerase Chain Reaction","longName":"3234683","preferredDefinition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Polymerase Chain Reaction","conceptCode":"C17003","definition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3158B0D-1572-9FBA-E040-BB89AD431012","latestVersionIndicator":"Yes","beginDate":"2011-05-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-12","modifiedBy":"SOKKERL","dateModified":"2023-12-01","changeDescription":"7-20-20 TMT updated concept with NCIt definition.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3158B0D-158B-9FBA-E040-BB89AD431012","beginDate":"2011-05-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-12","modifiedBy":"ONEDATA","dateModified":"2011-05-12","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0667617B-5E52-2B8F-E050-BB89AD435EBC","beginDate":"2014-10-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-10-27","modifiedBy":"ONEDATA","dateModified":"2014-10-27","deletedIndicator":"No"},{"value":"Karyotype","valueDescription":"Karyotyping","ValueMeaning":{"publicId":"4552511","version":"1","preferredName":"Karyotyping","longName":"4552511","preferredDefinition":"Mapping of the full chromosome set of the nucleus of a cell. The chromosome characteristics of an individual or a cell line are usually presented as a systematized array of metaphase chromosomes from a photomicrograph of a single cell nucleus arranged in pairs in descending order of size and according to the position of the centromere. (From Stedman, 25th ed)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Karyotyping","conceptCode":"C16768","definition":"The preparation, analysis, and interpretation of a karyotype, the representation of the chromosome set of a cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0667617B-5E5E-2B8F-E050-BB89AD435EBC","latestVersionIndicator":"Yes","beginDate":"2014-10-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-10-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0667617B-5E77-2B8F-E050-BB89AD435EBC","beginDate":"2014-10-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-10-27","modifiedBy":"ONEDATA","dateModified":"2014-10-27","deletedIndicator":"No"},{"value":"DNA Index","valueDescription":"DNA Index","ValueMeaning":{"publicId":"3630996","version":"1","preferredName":"DNA Index","longName":"3630996","preferredDefinition":"The ratio of the DNA content or chromosome number in a tumor sample compared to that in a normal sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DNA Index","conceptCode":"C86972","definition":"The ratio of the DNA content or chromosome number in a tumor sample compared to that in a normal sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF9627CC-1E85-F5AC-E040-BB89AD437262","latestVersionIndicator":"Yes","beginDate":"2012-11-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-11-28","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0667617B-5E81-2B8F-E050-BB89AD435EBC","beginDate":"2014-10-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-10-27","modifiedBy":"ONEDATA","dateModified":"2014-10-27","deletedIndicator":"No"},{"value":"SNP array","valueDescription":"Single Nucleotide Polymorphism Array","ValueMeaning":{"publicId":"6333960","version":"1","preferredName":"Single Nucleotide Polymorphism Array","longName":"6333960","preferredDefinition":"A genomic microarray-based method able to detect single nucleotide polymorphisms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Single Nucleotide Polymorphism Array","conceptCode":"C116151","definition":"A genomic microarray-based method able to detect single nucleotide polymorphisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E756556-3D0A-1506-E053-F662850A75B4","latestVersionIndicator":"Yes","beginDate":"2018-06-12","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-06-12","modifiedBy":"ONEDATA","dateModified":"2018-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6E756556-3D23-1506-E053-F662850A75B4","beginDate":"2018-06-12","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-06-12","modifiedBy":"ONEDATA","dateModified":"2018-06-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3234681","version":"1","preferredName":"Molecular Abnormality Test Method Type","preferredDefinition":"Abnormalities that occur in human cells and tissues and models of human cancer.:A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.:A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.:Type; a subdivision of a particular kind of thing.","longName":"C3910:C47891:C71460:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular Abnormality","conceptCode":"C3910","definition":"A molecular or cytogenetic abnormality which occurs in either human disease states or disease models.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Test","conceptCode":"C47891","definition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3158B0D-1518-9FBA-E040-BB89AD431012","latestVersionIndicator":"Yes","beginDate":"2011-05-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-12","modifiedBy":"ONEDATA","dateModified":"2011-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3158B0D-1529-9FBA-E040-BB89AD431012","latestVersionIndicator":"Yes","beginDate":"2011-05-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-12","modifiedBy":"HARTLEYG","dateModified":"2019-07-31","changeDescription":"Released per approval by B. McClure-Shimel. mc 5/12/11 Added 3 PVs for COG reuse. mc 10/27/2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"5655939","version":"1","longName":"BLGSP (Burkitt Lymphoma Genome Sequencing Project)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000269","version":"1","longName":"Enrollment Form","context":"OCG"}]}],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"},{"name":"HpoDpdChmDtcMtdTp","type":"COG GDE Short Name","context":"COG"},{"name":"OCG","type":"USED_BY","context":"OCG"}],"ReferenceDocuments":[{"name":"Methodology Used in Testing f","type":"Preferred Question Text","description":"Methodology Used in Testing for Genetic Abnormality","url":null,"context":"NCIP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"How was hypodiploidy detected?","url":null,"context":"COG"},{"name":"CTSP Question","type":"Alternate Question Text","description":"Method used for Genetic Abnormality Testing","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3158B0D-15A5-9FBA-E040-BB89AD431012","latestVersionIndicator":"Yes","beginDate":"2011-05-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-12","modifiedBy":"TSESU","dateModified":"2018-07-13","changeDescription":"Created for TCGA per request by B. McClure-Shimel. mc 5/12/11 Released per approval by B. McClure-Shimel. mc 5/19/11; Added alt text, ylu 3/27/17.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}